[SYRS] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
05-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 0.32%
YoY- -9.41%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 3,828 3,188 2,379 508 558 462 454 312.65%
PBT -19,486 -17,196 -17,226 -19,729 -19,793 -19,455 -16,461 11.86%
Tax 0 0 0 0 0 0 0 -
NP -19,486 -17,196 -17,226 -19,729 -19,793 -19,455 -16,461 11.86%
Tax Rate - - - - - - - -
Total Cost 23,314 20,384 19,605 20,237 20,351 19,917 16,915 23.77%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -509.04 -539.40 -724.09 -3,883.66 -3,547.13 -4,211.04 -3,625.77 -72.89%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -4.26 -3.76 -3.92 -4.60 -4.66 -4.67 -4.87 -8.51%
EPS Diluted -4.26 -3.76 -3.92 -4.49 -4.66 -4.67 -4.87 -8.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.